Robert Homolka, MS
Robert successfully worked in Phase 0 to IV projects and studies in small, medium and large pharmaceutical and biotech companies. He managed the execution of clinical trial activities across several therapeutic areas in line with GCPs, including IND opening studies for rosuvastatin (hypercholesterolemia.), AZD-7371 (depression), NXY-059 (stroke), ZD4953 (acute pain) and ZD8321 (acute respiratory distress disorder), SHP639 (increased ocular pressure). Robert helped developed and deployed an operating model to deliver clinical trials on expedited or standard timelines across multiple therapeutic areas and patient populations.